NeoTract’s UroLift® Prostate Implant Demonstrates Strong Safety and Efficacy Benefits with Minimally Invasive BPH Treatment
May 7, 2013 8:00 amPLEASANTON, CA, – NeoTract, Inc., today announced the successful results of the 206-patient L.I.F.T. IDE Study, a multi-center, randomized, blinded study in patients with Benign Prostatic Hyperplasia (BPH).... Read More